DK2114951T3 - Hidtil ukendte phosphodiesterase-inhibitorer - Google Patents

Hidtil ukendte phosphodiesterase-inhibitorer

Info

Publication number
DK2114951T3
DK2114951T3 DK08706922.5T DK08706922T DK2114951T3 DK 2114951 T3 DK2114951 T3 DK 2114951T3 DK 08706922 T DK08706922 T DK 08706922T DK 2114951 T3 DK2114951 T3 DK 2114951T3
Authority
DK
Denmark
Prior art keywords
unknown
phosphodiesterase inhibitors
phosphodiesterase
inhibitors
unknown phosphodiesterase
Prior art date
Application number
DK08706922.5T
Other languages
English (en)
Inventor
Jakob Felding
Simon Feldbaek Nielsen
Jens Christian Hojland Larsen
Bollu Ravindra Babu
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of DK2114951T3 publication Critical patent/DK2114951T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK08706922.5T 2007-02-28 2008-02-26 Hidtil ukendte phosphodiesterase-inhibitorer DK2114951T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90384907P 2007-02-28 2007-02-28
US94684907P 2007-06-28 2007-06-28
PCT/DK2008/000080 WO2008104175A2 (en) 2007-02-28 2008-02-26 Novel phosphodiesterase inhibitors

Publications (1)

Publication Number Publication Date
DK2114951T3 true DK2114951T3 (da) 2014-06-23

Family

ID=39415336

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08706922.5T DK2114951T3 (da) 2007-02-28 2008-02-26 Hidtil ukendte phosphodiesterase-inhibitorer

Country Status (21)

Country Link
US (1) US8338431B2 (da)
EP (1) EP2114951B9 (da)
JP (1) JP5501770B2 (da)
KR (1) KR101571654B1 (da)
AU (1) AU2008221121B2 (da)
BR (1) BRPI0807749B8 (da)
CA (1) CA2676933C (da)
CY (1) CY1115227T1 (da)
DK (1) DK2114951T3 (da)
ES (1) ES2478670T3 (da)
HR (1) HRP20140585T1 (da)
IL (1) IL200153A (da)
MX (1) MX2009009238A (da)
MY (1) MY150075A (da)
NZ (1) NZ578804A (da)
PL (1) PL2114951T3 (da)
PT (1) PT2114951E (da)
RS (1) RS53407B (da)
RU (1) RU2495043C2 (da)
SI (1) SI2114951T1 (da)
WO (1) WO2008104175A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120322776A1 (en) 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
RU2555339C2 (ru) 2009-12-22 2015-07-10 Лео Фарма А/С Нанокристаллы кальципотриола моногидрита
JP5732471B2 (ja) 2009-12-22 2015-06-10 レオ ファーマ アクティーゼルスカブ 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
KR101864578B1 (ko) * 2010-06-24 2018-06-07 레오 파마 에이/에스 포스포디에스테라제 억제제로서의 벤조디옥솔 또는 벤조디옥세핀 헤테로사이클릭 화합물
WO2013122855A1 (en) * 2012-02-14 2013-08-22 University Of Rochester Methods of increasing lymphatic transport
CN104334542A (zh) * 2012-06-04 2015-02-04 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物
WO2014083099A1 (en) * 2012-11-30 2014-06-05 Leo Pharma A/S A method of inhibiting the expression of il-22 in activated t-cells
AU2015279428B2 (en) * 2014-06-23 2018-02-15 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
ES2762987T3 (es) 2015-06-19 2020-05-26 Bristol Myers Squibb Co Macrociclos de diamida como inhibidores del factor XIA
TWI732808B (zh) 2015-12-18 2021-07-11 丹麥商理奧藥品公司 1,3－苯并二氧雜環戊烯雜環化合物之製備方法
JP6850886B2 (ja) * 2016-12-12 2021-03-31 レオ ファーマ アクティーゼルスカブ 置換ピラゾロアゼピン−４−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用
ES2874632T3 (es) * 2016-12-12 2021-11-05 Union Therapeutics As Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa
EP3551632B1 (en) * 2016-12-12 2024-06-12 UNION therapeutics A/S Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
WO2018234299A1 (en) * 2017-06-20 2018-12-27 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
TW201919682A (zh) 2017-08-08 2019-06-01 西班牙商阿爾米雷爾有限公司 活化Ｎｒｆ２路徑的新穎化合物
ES2935615T3 (es) 2017-12-15 2023-03-08 Union Therapeutics As Azetidina dihidrotienopiridinas sustituidas y su uso como inhibidores de la fosfodiesterasa
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507297D0 (en) 1995-04-07 1995-05-31 Rh Ne Poulenc Rorer Limited New composition of matter
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DK0771794T3 (da) * 1995-05-19 2006-09-11 Kyowa Hakko Kogyo Kk Oxygenholdige heterocykliske forbindelser
ATE239004T1 (de) * 1996-05-20 2003-05-15 Darwin Discovery Ltd Benzofuran carboxamide und ihre therapeutische anwendung
RU2203274C2 (ru) * 1996-08-28 2003-04-27 Дзе Проктер Энд Гэмбл Компани Спироциклические ингибиторы металлопротеаз
EP0943613A4 (en) * 1996-11-19 2002-07-10 Kyowa Hakko Kogyo Kk Oxygenic heterocyclic compounds
DE69813605T2 (de) * 1997-10-01 2004-02-12 Kyowa Hakko Kogyo Co., Ltd. Benzofuranderivate

Also Published As

Publication number Publication date
MX2009009238A (es) 2009-09-08
EP2114951B9 (en) 2015-09-02
SI2114951T1 (sl) 2014-08-29
KR101571654B1 (ko) 2015-11-25
PT2114951E (pt) 2014-07-17
EP2114951A2 (en) 2009-11-11
JP5501770B2 (ja) 2014-05-28
HRP20140585T1 (hr) 2014-09-12
BRPI0807749A2 (pt) 2014-06-17
KR20090126252A (ko) 2009-12-08
WO2008104175A2 (en) 2008-09-04
AU2008221121A1 (en) 2008-09-04
US8338431B2 (en) 2012-12-25
CY1115227T1 (el) 2017-01-04
EP2114951B1 (en) 2014-04-09
AU2008221121B2 (en) 2013-10-03
MY150075A (en) 2013-11-29
IL200153A (en) 2016-11-30
IL200153A0 (en) 2010-04-15
NZ578804A (en) 2012-04-27
RU2009135810A (ru) 2011-04-10
RU2495043C2 (ru) 2013-10-10
PL2114951T3 (pl) 2014-10-31
RS53407B (sr) 2014-10-31
JP2010519332A (ja) 2010-06-03
HK1138262A1 (en) 2010-08-20
BRPI0807749B8 (pt) 2022-09-06
CA2676933A1 (en) 2008-09-04
ES2478670T3 (es) 2014-07-22
US20100099688A1 (en) 2010-04-22
WO2008104175A3 (en) 2009-01-29
CA2676933C (en) 2015-09-29
BRPI0807749B1 (pt) 2021-01-05

Similar Documents

Publication Publication Date Title
DK2114951T3 (da) Hidtil ukendte phosphodiesterase-inhibitorer
IL280173A (en) Inhibitors of brutons tyrosine kinase
CY2020023I1 (el) Αναστολεiς βητα-λακταμασων
CY2019009I1 (el) Αναστολεις πρωτεϊνικων κινασων
CY2017016I1 (el) Αναστολεις πρωτεασωματος
BRPI0811212A2 (pt) Inibidores de p70 quinase
BRPI0814797A2 (pt) Inibidores dna-pk
ATE522535T1 (de) Pyrrolotriazin-kinasehemmer
BRPI0910668A2 (pt) inibidores de proteína quinases
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
BRPI0810365A2 (pt) Inibidores de mlc-1 de indol 7-substituído
DK2015754T3 (da) Anvendelse af dpp-iv-inhibitorer
CR10831A (es) INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
ATE519763T1 (de) Pyrrolopyrazin-kinasehemmer
BRPI0918846A2 (pt) inibidores de cinase heterocíclica
BRPI0806898A2 (pt) Inibidores de mek
ATE506358T1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
BRPI0918564A2 (pt) inibidores
ATE545417T1 (de) Pyrazoloä3,4-büpyridin-derivate als phosphodiesterasehemmer
DK2066662T3 (da) Serinhydrolaseinhibitorer
EP2162436A4 (en) NEW CASE OF RENININHIBITORS
BRPI0716198A2 (pt) Pirrolo-isoquinolinas como inibidores de cinase
ZA200905371B (en) Novel phosphodiesterase Inhibitors
DK2170891T3 (da) Pyrazolopyrimidinon-kinasehæmmere